Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $28.2900 (0.57%) ($27.7000 - $28.4500) on Wed. Aug. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.72% (three month average) | RSI | 57 | Latest Price | $28.2900(0.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -1.86% in a week (0% probabilities). VIXM(-22%) UUP(-17%) VXX(-12%) TBT(-6%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.86% (StdDev 3.72%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $29.44 | 5 Day Moving Average | $29.07(-2.68%) | 10 Day Moving Average | $29.56(-4.3%) | 20 Day Moving Average | $29.44(-3.91%) | To recent high | -31% | To recent low | 4% | Market Cap | $4.143b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |